Pro Medicus (OTCMKTS:PMCUF) Shares Gap Up – Should You Buy?

Pro Medicus Limited (OTCMKTS:PMCUF) gapped up before the market opened on Friday. The stock had previously closed at $103.76, but opened at $110.30. Pro Medicus shares last traded at $110.30, with a volume of 10 shares changing hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $155.00.

Pro Medicus Stock Performance

The stock has a fifty day simple moving average of $121.08 and a 200-day simple moving average of $112.01.

Pro Medicus Company Profile

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its primary product is the Visage enterprise imaging platform, which supports the storage, management, viewing and distribution of diagnostic images such as X-rays, CT scans and magnetic resonance images.

The company’s software is designed to help hospitals, radiology practices and other healthcare providers manage imaging workflows and enable clinicians to access diagnostic information across locations.